Costco bonds attracting bullish activity
Costco Wholesale Corp. bonds have been seeing bullish activity recently, according to information from the market-data company BondCliQ. Data from BondCliQ show there has an
Builder-confidence index rises for the first time in five months as mortgage rates fall
The numbers: Builder confidence rose in December for the first time in five months as mortgage rates fell. Builder confidence increased as rates fell
Opinion: Working a second job or thinking about it? Consider this investment instead.
“A few key considerations as you evaluate which ‘hustle’ is right for you.” In the world of financial literacy, a few items and actions
Dollar slips to 5-month low as US inflation cools
By Saqib Iqbal Ahmed NEW YORK (Reuters) -The edged down on Friday, hitting a near five-month low as data showed annual U.S. inflation slowed
PayPal: Don’t Keep Hanging On To A Poor Call (NASDAQ:PYPL)
Investors in PayPal Holdings, Inc. (NASDAQ:PYPL) are likely assessing whether the worst in its price decline could be over since my previous update in
10-year Treasury yield returns to lowest level since July after Bank of Japan keeps rates negative
Treasury yields finished mostly lower on Tuesday, with the benchmark 10-year rate returning to an almost five-month low, after the Bank of Japan kept
Seven tech stocks that can broaden your exposure beyond the ‘Magnificent Seven’ in 2024
During the bull market of 2023, the “Magnificent Seven” stocks have dominated financial media coverage, and rightly so. There is no question that this
U.S. housing starts surge to highest level since May
The numbers: Construction of new homes rose 14.8% in November, as builders scaled up new projects. The pace of construction increased as builders saw
A New Jersey financial pro just won nearly $500,000 on a sports bet. He’ll use it to pay off student loans.
After winning nearly $500,000 on a $5 sports bet, a New Jersey financial adviser said he is planning to follow some of the advice
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion
By Michael Erman and Manas Mishra (Reuters) -Bristol Myers Squibb on Friday agreed to buy Karuna Therapeutics (NASDAQ:) for $14 billion, gaining a promising
Most Read
